The Enterprise Value as of December 2024 (TTM) for Avalo Therapeutics, Inc. (AVTX) is 10.88M

According to Avalo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 10.88M. This represents a change of -125.30% compared to the average of -42982725.18 of the last 4 quarters.

Avalo Therapeutics, Inc. (AVTX) Historical Enterprise Value (quarterly & annually)

How has AVTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Avalo Therapeutics, Inc. over the last ten years is 85.18M. The current 10.88M Enterprise Value has changed 1.18% with respect to the historical average. Over the past ten years (40 quarters), AVTX's Enterprise Value was at its highest in in the December 2017 quarter at 24.01B. The Enterprise Value was at its lowest in in the March 2024 quarter at -92972080.10.

Avalo Therapeutics, Inc. (AVTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Avalo Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Avalo Therapeutics, Inc. (AVTX) Average Enterprise Value

How has AVTX Enterprise Value performed in the past?

The current Enterprise Value of Avalo Therapeutics, Inc. (AVTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Avalo Therapeutics, Inc. (AVTX) Enterprise Value vs. Peers

How is AVTX’s Enterprise Value compared to its peers?

Avalo Therapeutics, Inc.’s Enterprise Value is less than AnaptysBio, Inc. (247.57M), less than Arcellx, Inc. (4.10B), less than Structure Therapeutics Inc. (1.45B), less than Aerovate Therapeutics, Inc. (44.50M), less than ALX Oncology Holdings Inc. (90.25M), less than Anebulo Pharmaceuticals, Inc. (40.61M), less than Acrivon Therapeutics, Inc. Common Stock (154.58M), less than PMV Pharmaceuticals, Inc. (40.53M), less than Molecular Partners AG (107.67M), less than Mineralys Therapeutics, Inc. (539.76M), greater than Alzamend Neuro, Inc. (2.37M), greater than Virax Biolabs Group Limited (4.10M), less than Kiromic BioPharma, Inc. (13.26M), less than Benitec Biopharma Inc. (201.22M), less than Century Therapeutics, Inc. (89.16M), less than Edgewise Therapeutics, Inc. (2.76B), less than C4 Therapeutics, Inc. (280.63M), less than Cullinan Oncology, Inc. (614.81M), less than Miromatrix Medical Inc. (90.06M), less than ZIVO Bioscience, Inc. (78.24M), less than Bionomics Limited (1.25B),

Build a custom stock screener for Avalo Therapeutics, Inc. (AVTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avalo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Avalo Therapeutics, Inc. (AVTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Avalo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.